Serveur d'exploration Covid

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Differential neurodegenerative phenotypes are associated with heterogeneous voiding dysfunction in a coronavirus-induced model of multiple sclerosis.

Identifieur interne : 000596 ( PubMed/Checkpoint ); précédent : 000595; suivant : 000597

Differential neurodegenerative phenotypes are associated with heterogeneous voiding dysfunction in a coronavirus-induced model of multiple sclerosis.

Auteurs : Sanghee Lee [États-Unis] ; Balachandar Nedumaran [États-Unis] ; Joseph Hypolite [États-Unis] ; Brian Caldwell [États-Unis] ; Michael C. Rudolph [États-Unis] ; Anna P. Malykhina [États-Unis]

Source :

RBID : pubmed:31350464

Abstract

Patients with multiple sclerosis (MS) develop a variety of lower urinary tract symptoms (LUTS). We previously characterized a murine model of neurogenic bladder dysfunction induced by a neurotropic strain of a coronavirus. In the present study, we further study the role of long-lasting neurodegeneration on the development of neurogenic bladder dysfunction in mice with corona-virus induced encephalitis (CIE). Long-term follow up study revealed three phenotypes of neurodegenerative symptom development: recovery (REC group), chronic progression (C-PRO group) and chronic disease with relapsing-remitting episodes (C-RELAP group). The levels of IL-1β in REC group, IL-10 in C-RELAP group, and IL-1β, IL-6, IL-10 and TNF-α in C-PRO group were diminished in the brain. The levels of TNF-α in REC group and INF-γ, IL-2, TGF-β and TNF-α in the C-PRO group were also diminished in the urinary bladder. Mice in C-RELAP group showed a delayed recovery of voiding function. In vitro contractility studies determined a decreased basal detrusor tone and reduced amplitude of nerve-mediated contractions in C-RELAP group, whereas C-PRO group had elevated muscle-mediated contractions. In conclusion, mice with CIE developed three phenotypes of neurologic impairment mimicking different types of MS progression in humans and showed differential mechanisms driving neurogenic bladder dysfunction.

DOI: 10.1038/s41598-019-47407-x
PubMed: 31350464


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:31350464

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Differential neurodegenerative phenotypes are associated with heterogeneous voiding dysfunction in a coronavirus-induced model of multiple sclerosis.</title>
<author>
<name sortKey="Lee, Sanghee" sort="Lee, Sanghee" uniqKey="Lee S" first="Sanghee" last="Lee">Sanghee Lee</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Urology, University of California San Diego, La Jolla, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Urology, University of California San Diego, La Jolla, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nedumaran, Balachandar" sort="Nedumaran, Balachandar" uniqKey="Nedumaran B" first="Balachandar" last="Nedumaran">Balachandar Nedumaran</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co</wicri:regionArea>
<wicri:noRegion>Co</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hypolite, Joseph" sort="Hypolite, Joseph" uniqKey="Hypolite J" first="Joseph" last="Hypolite">Joseph Hypolite</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co</wicri:regionArea>
<wicri:noRegion>Co</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Caldwell, Brian" sort="Caldwell, Brian" uniqKey="Caldwell B" first="Brian" last="Caldwell">Brian Caldwell</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co</wicri:regionArea>
<wicri:noRegion>Co</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rudolph, Michael C" sort="Rudolph, Michael C" uniqKey="Rudolph M" first="Michael C" last="Rudolph">Michael C. Rudolph</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Endocrinology, Metabolism & Diabetes, University of Colorado Denver, Aurora, Co, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Endocrinology, Metabolism & Diabetes, University of Colorado Denver, Aurora, Co</wicri:regionArea>
<wicri:noRegion>Co</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Malykhina, Anna P" sort="Malykhina, Anna P" uniqKey="Malykhina A" first="Anna P" last="Malykhina">Anna P. Malykhina</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA. Anna.Malykhina@ucdenver.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co</wicri:regionArea>
<wicri:noRegion>Co</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2019">2019</date>
<idno type="RBID">pubmed:31350464</idno>
<idno type="pmid">31350464</idno>
<idno type="doi">10.1038/s41598-019-47407-x</idno>
<idno type="wicri:Area/PubMed/Corpus">000592</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000592</idno>
<idno type="wicri:Area/PubMed/Curation">000592</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000592</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000596</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000596</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Differential neurodegenerative phenotypes are associated with heterogeneous voiding dysfunction in a coronavirus-induced model of multiple sclerosis.</title>
<author>
<name sortKey="Lee, Sanghee" sort="Lee, Sanghee" uniqKey="Lee S" first="Sanghee" last="Lee">Sanghee Lee</name>
<affiliation wicri:level="2">
<nlm:affiliation>Department of Urology, University of California San Diego, La Jolla, California, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Urology, University of California San Diego, La Jolla, California</wicri:regionArea>
<placeName>
<region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Nedumaran, Balachandar" sort="Nedumaran, Balachandar" uniqKey="Nedumaran B" first="Balachandar" last="Nedumaran">Balachandar Nedumaran</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co</wicri:regionArea>
<wicri:noRegion>Co</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Hypolite, Joseph" sort="Hypolite, Joseph" uniqKey="Hypolite J" first="Joseph" last="Hypolite">Joseph Hypolite</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co</wicri:regionArea>
<wicri:noRegion>Co</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Caldwell, Brian" sort="Caldwell, Brian" uniqKey="Caldwell B" first="Brian" last="Caldwell">Brian Caldwell</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co</wicri:regionArea>
<wicri:noRegion>Co</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Rudolph, Michael C" sort="Rudolph, Michael C" uniqKey="Rudolph M" first="Michael C" last="Rudolph">Michael C. Rudolph</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Endocrinology, Metabolism & Diabetes, University of Colorado Denver, Aurora, Co, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Endocrinology, Metabolism & Diabetes, University of Colorado Denver, Aurora, Co</wicri:regionArea>
<wicri:noRegion>Co</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Malykhina, Anna P" sort="Malykhina, Anna P" uniqKey="Malykhina A" first="Anna P" last="Malykhina">Anna P. Malykhina</name>
<affiliation wicri:level="1">
<nlm:affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA. Anna.Malykhina@ucdenver.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co</wicri:regionArea>
<wicri:noRegion>Co</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series>
<title level="j">Scientific reports</title>
<idno type="eISSN">2045-2322</idno>
<imprint>
<date when="2019" type="published">2019</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Patients with multiple sclerosis (MS) develop a variety of lower urinary tract symptoms (LUTS). We previously characterized a murine model of neurogenic bladder dysfunction induced by a neurotropic strain of a coronavirus. In the present study, we further study the role of long-lasting neurodegeneration on the development of neurogenic bladder dysfunction in mice with corona-virus induced encephalitis (CIE). Long-term follow up study revealed three phenotypes of neurodegenerative symptom development: recovery (REC group), chronic progression (C-PRO group) and chronic disease with relapsing-remitting episodes (C-RELAP group). The levels of IL-1β in REC group, IL-10 in C-RELAP group, and IL-1β, IL-6, IL-10 and TNF-α in C-PRO group were diminished in the brain. The levels of TNF-α in REC group and INF-γ, IL-2, TGF-β and TNF-α in the C-PRO group were also diminished in the urinary bladder. Mice in C-RELAP group showed a delayed recovery of voiding function. In vitro contractility studies determined a decreased basal detrusor tone and reduced amplitude of nerve-mediated contractions in C-RELAP group, whereas C-PRO group had elevated muscle-mediated contractions. In conclusion, mice with CIE developed three phenotypes of neurologic impairment mimicking different types of MS progression in humans and showed differential mechanisms driving neurogenic bladder dysfunction.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Status="In-Data-Review" Owner="NLM">
<PMID Version="1">31350464</PMID>
<DateRevised>
<Year>2020</Year>
<Month>03</Month>
<Day>06</Day>
</DateRevised>
<Article PubModel="Electronic">
<Journal>
<ISSN IssnType="Electronic">2045-2322</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>9</Volume>
<Issue>1</Issue>
<PubDate>
<Year>2019</Year>
<Month>Jul</Month>
<Day>26</Day>
</PubDate>
</JournalIssue>
<Title>Scientific reports</Title>
<ISOAbbreviation>Sci Rep</ISOAbbreviation>
</Journal>
<ArticleTitle>Differential neurodegenerative phenotypes are associated with heterogeneous voiding dysfunction in a coronavirus-induced model of multiple sclerosis.</ArticleTitle>
<Pagination>
<MedlinePgn>10869</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1038/s41598-019-47407-x</ELocationID>
<Abstract>
<AbstractText>Patients with multiple sclerosis (MS) develop a variety of lower urinary tract symptoms (LUTS). We previously characterized a murine model of neurogenic bladder dysfunction induced by a neurotropic strain of a coronavirus. In the present study, we further study the role of long-lasting neurodegeneration on the development of neurogenic bladder dysfunction in mice with corona-virus induced encephalitis (CIE). Long-term follow up study revealed three phenotypes of neurodegenerative symptom development: recovery (REC group), chronic progression (C-PRO group) and chronic disease with relapsing-remitting episodes (C-RELAP group). The levels of IL-1β in REC group, IL-10 in C-RELAP group, and IL-1β, IL-6, IL-10 and TNF-α in C-PRO group were diminished in the brain. The levels of TNF-α in REC group and INF-γ, IL-2, TGF-β and TNF-α in the C-PRO group were also diminished in the urinary bladder. Mice in C-RELAP group showed a delayed recovery of voiding function. In vitro contractility studies determined a decreased basal detrusor tone and reduced amplitude of nerve-mediated contractions in C-RELAP group, whereas C-PRO group had elevated muscle-mediated contractions. In conclusion, mice with CIE developed three phenotypes of neurologic impairment mimicking different types of MS progression in humans and showed differential mechanisms driving neurogenic bladder dysfunction.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Lee</LastName>
<ForeName>Sanghee</ForeName>
<Initials>S</Initials>
<AffiliationInfo>
<Affiliation>Department of Urology, University of California San Diego, La Jolla, California, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Nedumaran</LastName>
<ForeName>Balachandar</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Hypolite</LastName>
<ForeName>Joseph</ForeName>
<Initials>J</Initials>
<AffiliationInfo>
<Affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Caldwell</LastName>
<ForeName>Brian</ForeName>
<Initials>B</Initials>
<AffiliationInfo>
<Affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Rudolph</LastName>
<ForeName>Michael C</ForeName>
<Initials>MC</Initials>
<Identifier Source="ORCID">http://orcid.org/0000-0002-6147-212X</Identifier>
<AffiliationInfo>
<Affiliation>Division of Endocrinology, Metabolism & Diabetes, University of Colorado Denver, Aurora, Co, USA.</Affiliation>
</AffiliationInfo>
<AffiliationInfo>
<Affiliation>NORC Metabolic and Cellular Analysis Core Center for Women's Health Research, University of Colorado Denver, Aurora, Co, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Malykhina</LastName>
<ForeName>Anna P</ForeName>
<Initials>AP</Initials>
<AffiliationInfo>
<Affiliation>Division of Urology, Department of Surgery, University of Colorado Denver, Aurora, Co, USA. Anna.Malykhina@ucdenver.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>P20 DK097819</GrantID>
<Acronym>DK</Acronym>
<Agency>NIDDK NIH HHS</Agency>
<Country>United States</Country>
</Grant>
<Grant>
<GrantID>DK097819</GrantID>
<Agency>U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)</Agency>
<Country></Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2019</Year>
<Month>07</Month>
<Day>26</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>England</Country>
<MedlineTA>Sci Rep</MedlineTA>
<NlmUniqueID>101563288</NlmUniqueID>
<ISSNLinking>2045-2322</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2019</Year>
<Month>04</Month>
<Day>08</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2019</Year>
<Month>07</Month>
<Day>16</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2019</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2019</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2019</Year>
<Month>7</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">31350464</ArticleId>
<ArticleId IdType="doi">10.1038/s41598-019-47407-x</ArticleId>
<ArticleId IdType="pii">10.1038/s41598-019-47407-x</ArticleId>
<ArticleId IdType="pmc">PMC6659655</ArticleId>
</ArticleIdList>
<ReferenceList>
<Reference>
<Citation>Arch Phys Med Rehabil. 1999 Apr;80(4):437-41</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10206607</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol. 1999 Nov;246(11):1027-32</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">10631634</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurourol Urodyn. 2000;19(6):689-99</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11071700</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2001 Oct 1;167(7):4091-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11564831</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol. 2002 Jan;249(1):1-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11954855</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Neurosci. 2002 Apr;3(4):291-301</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">11967559</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Sci. 1992 Dec;113(2):177-86</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">1336796</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Natl Cancer Inst. 1961 Jul;27:29-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">13766009</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Br Med J. 1965 May 15;1(5445):1265-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">14278814</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mult Scler. 2004 Aug;10(4):455-61</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15327046</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>AJNR Am J Neuroradiol. 2005 Jun-Jul;26(6):1548-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">15956528</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Physiol. 2007 Jan 15;578(Pt 2):439-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">17068103</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Neurosurg Psychiatry. 2009 May;80(5):470-7</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19372287</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Immunol. 2009 Jun;9(6):393-407</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19444307</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2009 Dec 1;183(11):7169-77</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">19890056</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Indian J Urol. 2010 Jan-Mar;26(1):26-35</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20535281</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Clin Exp Immunol. 2010 Oct;162(1):1-11</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">20682002</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Handb Exp Pharmacol. 2011;(202):425-51</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21290238</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurourol Urodyn. 2011 Mar;30(3):339-43</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21305587</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Regul Integr Comp Physiol. 2011 Jun;300(6):R1392-400</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">21474425</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Physiol. 2012 Mar 15;590(6):1465-80</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22250215</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Clin Invest. 2012 Apr;122(4):1180-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22466660</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Vis Exp. 2012 Aug 21;(66):e3869</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22929055</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Renal Physiol. 2012 Nov 1;303(9):F1363-9</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">22993071</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroinflammation. 2013 Jan 11;10:3</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">23305398</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Purinergic Signal. 2014 Mar;10(1):103-55</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">24265069</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Am J Physiol Renal Physiol. 2014 Sep 1;307(5):F612-22</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25007876</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Eur Neurol. 2014;72 Suppl 1:1-5</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25278115</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2014 Oct 13;9(10):e109314</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25310403</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Urol. 1989 Sep;142(3):850-4</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">2549275</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>PLoS One. 2015 Feb 03;10(2):e0116827</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25647072</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Mult Scler Relat Disord. 2014 Mar;3(2):227-36</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25878010</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neuroepidemiology. 2015;44(4):199-214</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">25997994</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Nat Rev Urol. 2016 May;13(5):275-88</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27030526</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol. 2016 Oct;263(10):1969-83</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">27393117</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurourol Urodyn. 2017 Sep;36(7):1832-1838</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28084625</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Immunol. 2017 May 15;198(10):3869-3877</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">28356385</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Curr Neurol Neurosci Rep. 2018 Jun 28;18(8):54</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">29956001</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Neurourol Urodyn. 2019 Jan;38(1):239-247</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">30311665</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Urol. 1984 Sep;132(3):499-502</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">6471185</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>Arch Neurol. 1995 Sep;52(9):862-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7661722</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurosci Res. 1995 Jan 1;40(1):10-21</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7714917</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroimmunol. 1994 May;51(2):153-67</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">7910169</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Sci. 1993 Dec 1;120(1):99-106</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8289087</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurol Neurosurg Psychiatry. 1993 Mar;56(3):245-50</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8459239</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neurovirol. 1996 Dec;2(6):361-76</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">8972418</ArticleId>
</ArticleIdList>
</Reference>
<Reference>
<Citation>J Neuroimmunol. 1998 Aug 1;88(1-2):30-8</Citation>
<ArticleIdList>
<ArticleId IdType="pubmed">9688321</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>États-Unis</li>
</country>
<region>
<li>Californie</li>
</region>
</list>
<tree>
<country name="États-Unis">
<region name="Californie">
<name sortKey="Lee, Sanghee" sort="Lee, Sanghee" uniqKey="Lee S" first="Sanghee" last="Lee">Sanghee Lee</name>
</region>
<name sortKey="Caldwell, Brian" sort="Caldwell, Brian" uniqKey="Caldwell B" first="Brian" last="Caldwell">Brian Caldwell</name>
<name sortKey="Hypolite, Joseph" sort="Hypolite, Joseph" uniqKey="Hypolite J" first="Joseph" last="Hypolite">Joseph Hypolite</name>
<name sortKey="Malykhina, Anna P" sort="Malykhina, Anna P" uniqKey="Malykhina A" first="Anna P" last="Malykhina">Anna P. Malykhina</name>
<name sortKey="Nedumaran, Balachandar" sort="Nedumaran, Balachandar" uniqKey="Nedumaran B" first="Balachandar" last="Nedumaran">Balachandar Nedumaran</name>
<name sortKey="Rudolph, Michael C" sort="Rudolph, Michael C" uniqKey="Rudolph M" first="Michael C" last="Rudolph">Michael C. Rudolph</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000596 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000596 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:31350464
   |texte=   Differential neurodegenerative phenotypes are associated with heterogeneous voiding dysfunction in a coronavirus-induced model of multiple sclerosis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:31350464" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidV1 

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Fri Mar 27 18:14:15 2020. Site generation: Sun Jan 31 15:15:08 2021